Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma-Reference-Cited by-同舟云学术

Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma

Published:2014-12-23 Issue:7 Volume:121 Page:1128-1137
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Herman Joseph M.¹,Chang Daniel T.²,Goodman Karyn A.³,Dholakia Avani S.¹,Raman Siva P.⁴,Hacker‐Prietz Amy¹,Iacobuzio‐Donahue Christine A.⁵,Griffith Mary E.¹,Pawlik Timothy M.⁶,Pai Jonathan S.²,O'Reilly Eileen⁷,Fisher George A.⁸,Wild Aaron T.¹,Rosati Lauren M.¹,Zheng Lei⁹,Wolfgang Christopher L.⁶,Laheru Daniel A.⁹,Columbo Laurie A.²,Sugar Elizabeth A.¹⁰,Koong Albert C.²

Affiliation:

1. Department of Radiation Oncology & Molecular Radiation SciencesSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of MedicineBaltimore Maryland

2. Department of Radiation Oncology, Stanford Cancer Institute, Stanford University School of MedicineStanford California

3. Department of Radiation OncologyMemorial Sloan Kettering Cancer CenterNew York New York

4. Department of RadiologySidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of MedicineBaltimore Maryland

5. Department of PathologySidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of MedicineBaltimore Maryland

6. Department of SurgerySidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of MedicineBaltimore Maryland

7. Department of Medical OncologyMemorial Sloan Kettering Cancer CenterNew York New York

8. Department of Medical OncologyStanford Cancer Institute, Stanford University School of MedicineStanford California

9. Department of Medical OncologySidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of MedicineBaltimore Maryland

10. Department of Biostatistics and EpidemiologyJohns Hopkins University School of MedicineBaltimore Maryland

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.29161

Reference32 articles.

1. Cancer statistics, 2012

2. Pancreatic Adenocarcinoma, Version 2.2012

3. Randomized Phase III Multi-Institutional Study of TNFerade Biologic With Fluorouracil and Radiotherapy for Locally Advanced Pancreatic Cancer: Final Results

4. Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

5. A Phase I/II Trial of Intensity Modulated Radiation (IMRT) Dose Escalation With Concurrent Fixed-dose Rate Gemcitabine (FDR-G) in Patients With Unresectable Pancreatic Cancer

Cited by 446 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosimetric predictors of acute and late gastrointestinal toxicities in stereotactic online adaptive magnetic resonance-guided radiotherapy (SMART) for locally advanced pancreatic adenocarcinoma;Radiotherapy and Oncology;2024-11

2. Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery;Strahlentherapie und Onkologie;2024-07-12

3. Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer;Clinical and Experimental Gastroenterology;2024-07

4. SBRT for Pancreatic Cancer: A Radiosurgery Society Case-Based Practical Guidelines to Challenging Cases;Practical Radiation Oncology;2024-07

5. Outcomes of phosphorus-32 microparticle intratumoral implantation added to chemotherapy in patients with metastatic pancreatic adenocarcinoma;iGIE;2024-07